Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Rajendra P et al. | 2012 | intact cell/cell culture, sheep primary lymphocytes | 50/60 Hz, magnetic field | 5–100 µT |
| Maes A et al. | 2015 | intact cell/cell culture, C3A cells (clonal derivative of Hep G2, a human liver carcinoma cell line) | magnetic field, 50/60 Hz | 5–500 µT |
| Svedenstal BM et al. | 1999 | animal, mouse/CBA/Ca, whole body | magnetic field, 50/60 Hz, power transmission line | 8 µT |
| Kesari KK et al. | 2016 | intact cell/cell culture, SH-SY5Y cells (human neuroblastoma cell line) and C6 (rat glioma cell line) | magnetic field, 50/60 Hz | 10–30 µT |
| Wilson JW et al. | 2014 | animal, mouse/BALB/c Œ CBA/Ca F1 hybrid, whole body | magnetic field, 50/60 Hz | 10–300 µT |
| Lai H et al. | 2004 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 10–500 µT |
| Jin YB et al. | 2012 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts) and WI38 cells (human lung fibroblasts), normal and transfected with a c-Myc-containing vector or with an empty vetor | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
| Villarini M et al. | 2017 | intact cell/cell culture, SH-SY5Y and SK-N-BE-2 (human neuroblastoma cell lines) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 0.01–1 mT |
| Hosseinabadi MB et al. | 2019 | human | magnetic field, low frequency, 50/60 Hz, occupational | 11.3–18.9 µT |
| Bagheri Hosseinabadi M et al. | 2020 | human | electric field, magnetic field, 50/60 Hz, occupational | 16.5 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
